|Bid||40.55 x 1300|
|Ask||44.10 x 1400|
|Day's range||40.46 - 42.59|
|52-week range||16.87 - 49.22|
|Beta (5Y monthly)||1.33|
|PE ratio (TTM)||N/A|
|Earnings date||06 May 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||47.40|
Natera, Inc. (NTRA) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Ladies and gentlemen, thank you for joining us for the Natera, Inc. first-quarter 2020 earnings conference call. Also on the line is Steve Chapman, our CEO; Bob Schueren, chief operating officer; Solomon Moshkevich, general manager of oncology; and Paul Billings, chief medical officer. During the course of this conference call, we will make forward-looking statements regarding future events and our anticipated future performance, such as our operational and financial outlook, our assumptions for that outlook, the impact of the COVID-19 pandemic on our business and operations, market size and partnerships, clinical studies, opportunities and strategies and expectations for various current and future products, including product capabilities, expected release dates, reimbursement coverage and related effects on our financial and operating results.
Natera (NTRA) delivered earnings and revenue surprises of 21.05% and 4.96%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Natera (NTRA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Andrew Chung of 1955 Capital Speaking at the Swiss Energy and Climate Summit in 2015 By IPO Edge Staff The climate has long been a hot button topic for politicians and activists, and it is becoming one for investors too. Millennials, now the largest demographic in the United States, are far more likely to choose […]
If you're interested in Natera, Inc. (NASDAQ:NTRA), then you might want to consider its beta (a measure of share price...
Natera (NTRA) delivered earnings and revenue surprises of 0.00% and 3.80%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Natera (NTRA) delivered earnings and revenue surprises of 15.79% and 10.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?